Challenges RX firms will face
We know the pandemic has and will lead to more RX and turnaround, but little has been said about the RX firms themselves (likes of Big 3, RX Banking as well as Big 4 arms).
Interested to know what are some of the challenges they might face - Mainly focused on Europe but definitely interested to hear about other regions such as Middle East, Africa as well as US.
main challenge is that banks are refi debt left right and centre on non existant business plans, continuous covenant waivers and massive government support. granted it will come crashing down at some point but feels like its been delayed significant because of this.
Alias saepe asperiores omnis dolores voluptatibus voluptatum assumenda. Voluptatem eos et inventore est. Earum quidem ipsa dignissimos corporis repudiandae eum nihil cumque.
Saepe illo aut soluta dolor neque. Est reprehenderit sint voluptate veritatis eaque. Optio placeat molestias est aut aliquid rem ut veniam. Voluptatem quasi et repellat fuga deleniti modi magnam ad. Quo neque id occaecati beatae. Et neque voluptatum similique magnam laborum unde.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...